Mersana Therapeutics Inc. (MRSN)
NASDAQ: MRSN
· Real-Time Price · USD
7.26
0.09 (1.26%)
At close: Sep 26, 2025, 3:14 PM
Mersana Therapeutics Revenue
Mersana Therapeutics reported an annual revenue of $40.5M, reflecting a 9.88% growth. For the quarter ending June 30, 2025, Mersana Therapeutics generated $3.06M in revenue.
Revenue (ttm)
40.5M
Revenue Growth
9.88%
Price / Sales Ratio
4.33
Revenue / Employee
397.03K
Employees
102
Market Cap
36.26M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 40.5M | +9.88% |
| Dec 31, 2023 | 36.85M | +38.65% |
| Dec 31, 2022 | 26.58M | +61716.28% |
| Dec 31, 2021 | 43K | -94.81% |
| Dec 31, 2020 | 828K | -98.03% |
| Dec 31, 2019 | 42.12M | +297.61% |
| Dec 31, 2018 | 10.59M | -39.62% |
| Dec 31, 2017 | 17.55M | -30.30% |
| Dec 31, 2016 | 25.17M | +142.99% |
| Dec 31, 2015 | 10.36M | n/a |